Results
Supriya Lifescience FY26 Revenue Grows 19% to ₹828 Crore
Supriya Lifescience reported 18.9% revenue growth to ₹827.9 crore and 11.2% PAT increase to ₹209.1 crore in FY26 with strong export performance.
The company declared a final dividend of ₹1 per share a
